Key facts
- EXEL - EXELIXIS, INC. has 26 insiders with reported activity on this page.
- Net insider value flow over the last year: -$38,780,280.
- Recent transaction rows are available for direct filing-level review.
Insider Transactions Reported by 26 Insiders of EXELIXIS, INC.
- Symbol
- EXEL on Nasdaq
- Location
- Alameda, CA
Change
- Buy value: $1,187,235; sell value: $39,967,515.
- Net share flow: -875,446.
Research use
- This page gives a plain-language issuer insider context before you inspect transaction-level evidence.
- Use the filing links below to verify timestamps, codes, and ownership impacts directly from SEC forms.
Evidence
Filed on Form 4
See Original Filing
Issuer insider activity is sourced from SEC Forms 3, 4, and 5.
Insider trading overview
Last 12 monthsNet insider flow leans to selling over the last 12 months. Net value: -$38,780,280.
Buys
$1,187,235
Shares: 27,532
Insiders: 1
Sells
$39,967,515
Shares: 902,978
Insiders: 12
Net
-$38,780,280
Shares: -875,446
Insiders: -11
| Window (months) | Buy shares | Sell shares | Buy $ | Sell $ | Net $ |
|---|---|---|---|---|---|
| 0-3 | 0 | 161,982 | $0 | $7,742,501 | -$7,742,501 |
| 3-6 | 0 | 469,388 | $0 | $20,604,572 | -$20,604,572 |
| 6-9 | 27,532 | 245,235 | $1,187,235 | $10,490,619 | -$9,303,384 |
| 9-12 | 0 | 26,373 | $0 | $1,129,823 | -$1,129,823 |
EXELIXIS, INC. executives and other stock owners filed with the SEC include:
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Valuation | Report Date |
|---|---|---|---|---|---|---|
| Michael Morrissey | President and CEO, Director | $145,142,461 | Median | 15 May 2026 | ||
| David Edward Johnson | Director | $67,687,536 | +$1,187,235 | +1.8% | Mixed | 25 Nov 2025 |
| Stelios Papadopoulos | Director | $51,790,879 | -$4,355,000 | -7.8% | Filing P/S | 12 Nov 2025 |
| Christopher J. Senner | EVP and CFO | $47,732,639 | -$4,556,048 | -8.7% | Mixed | 15 May 2026 |
| Jeffrey Hessekiel | EVP & General Counsel | $32,059,538 | Mixed | 15 May 2025 | ||
| Dana Aftab | EVP, Research and Development | $27,622,317 | -$5,513,496 | -17% | Median | 15 May 2026 |
| Amy C. Peterson | EVP Prod Dev & Med Aff & CMO | $21,161,419 | Filing P/S | 15 May 2025 | ||
| Patrick J. Haley | EVP, Commercial | $17,813,948 | -$7,597,269 | -30% | Filing P/S | 20 May 2026 |
| Gisela Schwab | Pres, Prod Dev & Med Aff & CMO | $16,092,480 | Mixed | 26 Jul 2021 | ||
| Jack L. Wyszomierski | Director | $12,320,247 | -$4,706,935 | -28% | Filing P/S | 18 Feb 2026 |
| Peter Lamb | EVP, Scientific Strategy & CSO | $9,785,520 | Mixed | 15 Dec 2022 | ||
| Lance Willsey | Director | $9,702,127 | Mixed | 26 May 2022 | ||
| Vicki L. Goodman | EVP, Prod Dev & Med Aff &CMO | $7,032,970 | Mixed | 03 Apr 2023 | ||
| Charles Cohen | Director | $5,975,033 | Mixed | 31 Dec 2021 | ||
| Brenda Hefti | SVP and General Counsel | $5,597,573 | -$1,154,264 | -17% | Mixed | 15 May 2026 |
| George Poste | Director | $5,431,810 | -$2,742,600 | -34% | Filing P/S | 07 May 2026 |
| Maria C. Freire | Director | $4,637,674 | -$949,164 | -17% | Filing P/S | 07 May 2026 |
| Marchesi Vincent T. | Director | $2,148,589 | Mixed | 26 May 2022 | ||
| Tomas J. Heyman | Director | $1,529,339 | Mixed | 29 May 2025 | ||
| Jacqueline Wright | Director | $1,183,142 | Mixed | 01 Jun 2023 | ||
| Bob Oliver | Director | $927,168 | -$1,325,339 | -59% | Filing P/S | 13 Feb 2026 |
| Julie Smith | Director | $912,136 | -$4,687,346 | -84% | Filing P/S | 17 Feb 2026 |
| Alan M. Garber | Director | $857,229 | Filing P/S | 21 Mar 2024 | ||
| Mary C. Beckerle | Director | $849,037 | -$1,406,060 | -62% | Filing P/S | 07 May 2026 |
| Sue Gail Eckhardt | Director | $767,375 | -$973,994 | -56% | Filing P/S | 13 Feb 2026 |
| Carl B. Feldbaum | Director | $427,505 | Mixed | 09 Feb 2023 |
Top shareholders of EXELIXIS, INC. (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| BlackRock, Inc. |
13F
13D/G
|
Company |
10%
from 13D/G
|
30,816,309
|
$1,321,711,509 | — | 31 Mar 2026 | |
| Farallon Capital Partners, L.P. |
13D/G
|
Dapice Joshua J. |
5.9%
|
15,709,500
|
$650,216,205 | -$121,107,140 | 01 Jan 2026 | |
| AQR CAPITAL MANAGEMENT LLC |
13D/G
13F
|
Company |
5.1%
|
13,658,388
|
$601,788,575 | $0 | 31 Dec 2025 | |
| VANGUARD CAPITAL MANAGEMENT LLC |
13D/G
13F
|
Vanguard Capital Management · Company |
5.1%
|
13,233,247
|
$567,573,964 | $0 | 31 Mar 2026 | |
| Michael Morrissey |
3/4/5
|
President and CEO, Director |
1.3%
|
3,384,063
|
$145,142,461 | — | 15 May 2026 | |
| Stelios Papadopoulos |
3/4/5
|
Director |
0.46%
|
1,189,228
|
$51,790,879 | -$4,355,000 | 12 Nov 2025 | |
| Christopher J. Senner |
3/4/5
|
EVP and CFO |
0.37%
|
955,040
|
$47,732,639 | -$4,556,048 | 15 May 2026 | |
| Jeffrey Hessekiel |
3/4/5
|
EVP & General Counsel |
0.27%
|
694,395
|
$32,059,538 | — | 15 May 2025 | |
| Dana Aftab |
3/4/5
|
EVP, Research and Development |
0.25%
|
644,027
|
$27,622,317 | -$5,513,496 | 15 May 2026 | |
| Patrick J. Haley |
3/4/5
|
EVP, Commercial |
0.14%
|
357,638
|
$17,813,948 | -$7,597,269 | 20 May 2026 | |
| Jack L. Wyszomierski |
3/4/5
|
Director |
0.11%
|
279,942
|
$12,320,247 | -$4,706,935 | 18 Feb 2026 | |
| George Poste |
3/4/5
|
Director |
0.05%
|
118,832
|
$5,431,810 | -$2,742,600 | 07 May 2026 | |
| Brenda Hefti |
3/4/5
|
SVP and General Counsel |
0.04%
|
112,289
|
$5,597,573 | -$1,154,264 | 15 May 2026 | |
| Maria C. Freire |
3/4/5
|
Director |
0.04%
|
100,819
|
$4,637,674 | -$949,164 | 07 May 2026 | |
| Tomas J. Heyman |
3/4/5
|
Director |
0.02%
|
42,282
|
$1,529,339 | — | 29 May 2025 | |
| Julie Smith |
3/4/5
|
Director |
0.01%
|
20,590
|
$912,136 | -$4,687,346 | 17 Feb 2026 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
5.3%
|
13,726,993
|
$588,750,730 | — | 31 Mar 2026 | |
| FARALLON CAPITAL MANAGEMENT LLC |
13F
|
Company |
5%
|
13,111,010
|
$562,331,219 | — | 31 Mar 2026 | |
| VANGUARD PORTFOLIO MANAGEMENT LLC |
13F
|
Company |
4.6%
|
12,085,273
|
$518,337,359 | — | 31 Mar 2026 | |
| STATE STREET CORP |
13F
|
Company |
4%
|
10,298,439
|
$441,700,049 | — | 31 Mar 2026 | |
| FULLER & THALER ASSET MANAGEMENT, INC. |
13F
|
Company |
3.3%
|
8,542,236
|
$366,376,513 | — | 31 Mar 2026 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
3%
|
7,795,610
|
$334,403,921 | — | 31 Mar 2026 | |
| LSV ASSET MANAGEMENT |
13F
|
Company |
3%
|
7,745,715
|
$332,214,000 | — | 31 Mar 2026 | |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP |
13F
|
Company |
1.9%
|
4,834,625
|
$207,357,066 | — | 31 Mar 2026 | |
| Invesco Ltd. |
13F
|
Company |
1.7%
|
4,314,381
|
$185,043,801 | — | 31 Mar 2026 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
1.7%
|
4,299,597
|
$184,390,554 | — | 31 Mar 2026 | |
| MORGAN STANLEY |
13F
|
Company |
1.6%
|
4,178,236
|
$179,204,623 | — | 31 Mar 2026 | |
| Nuveen, LLC |
13F
|
Company |
1.5%
|
3,782,734
|
$162,241,461 | — | 31 Mar 2026 | |
| D. E. Shaw & Co., Inc. |
13F
|
Company |
1.4%
|
3,603,063
|
$154,535,372 | — | 31 Mar 2026 | |
| ASSETMARK, INC |
13F
|
Company |
1.3%
|
3,388,920
|
$145,350,779 | — | 31 Mar 2026 | |
| LOS ANGELES CAPITAL MANAGEMENT LLC |
13F
|
Company |
1.2%
|
3,102,634
|
$133,071,973 | — | 31 Mar 2026 | |
| CAISSE DE DEPOT ET PLACEMENT DU QUEBEC |
13F
|
Company |
0.98%
|
2,542,819
|
$109,061,507 | — | 31 Mar 2026 | |
| FIRST TRUST ADVISORS LP |
13F
|
Company |
0.98%
|
2,534,992
|
$108,725,775 | — | 31 Mar 2026 | |
| Stephens Investment Management Group LLC |
13F
|
Company |
0.97%
|
2,524,500
|
$108,275,805 | — | 31 Mar 2026 | |
| UBS Group AG |
13F
|
Company |
0.92%
|
2,393,513
|
$102,657,773 | — | 31 Mar 2026 | |
| FMR LLC |
13F
|
Company |
0.89%
|
2,326,390
|
$99,778,849 | — | 31 Mar 2026 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.89%
|
2,318,236
|
$99,429,142 | — | 31 Mar 2026 | |
| TWO SIGMA INVESTMENTS, LP |
13F
|
Company |
0.85%
|
2,206,212
|
$94,624,433 | — | 31 Mar 2026 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.84%
|
2,195,095
|
$94,147,624 | — | 31 Mar 2026 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.81%
|
2,118,574
|
$90,865,639 | — | 31 Mar 2026 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.76%
|
1,986,035
|
$85,181,021 | — | 31 Mar 2026 | |
| Allspring Global Investments Holdings, LLC |
13F
|
Company |
0.66%
|
1,707,715
|
$75,207,769 | — | 31 Mar 2026 | |
| FRANKLIN RESOURCES INC |
13F
|
Company |
0.64%
|
1,663,917
|
$71,365,400 | — | 31 Mar 2026 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.63%
|
1,644,737
|
$70,542,770 | — | 31 Mar 2026 | |
| VANGUARD FIDUCIARY TRUST CO |
13F
|
Company |
0.63%
|
1,633,700
|
$70,069,393 | — | 31 Mar 2026 | |
| SEI INVESTMENTS CO |
13F
|
Company |
0.63%
|
1,629,670
|
$69,895,948 | — | 31 Mar 2026 | |
| THRIVENT FINANCIAL FOR LUTHERANS |
13F
|
Company |
0.6%
|
1,568,627
|
$67,278,000 | — | 31 Mar 2026 | |
| Caligan Partners LP |
13F
|
Company |
0.6%
|
1,553,262
|
$66,619,407 | — | 31 Mar 2026 | |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC |
13F
|
Company |
0.5%
|
1,292,017
|
$55,414,608 | — | 31 Mar 2026 | |
| Robeco Institutional Asset Management B.V. |
13F
|
Company |
0.5%
|
1,289,101
|
$55,289,539 | — | 31 Mar 2026 |
Recent Insider Transactions by Companies or Individuals for EXELIXIS, INC.
Showing up to 300 most recent insider transactions from the last 12 months.
| Insider | Symbol | Class | Transaction | % | Value $ | * Price $ | Shares | Shares Owned | Date | Ownership |
|---|---|---|---|---|---|---|---|---|---|---|
| Patrick J. Haley | EXEL | Common Stock | Sale | -8.24% | $1,599,399 | $49.81 | -32,110 | 357,638 | 20 May 2026 | Direct |
| Michael Morrissey | EXEL | Common Stock | Gift | 6.6% | 124,047 | 2,004,327 | 18 May 2026 | By Trust | ||
| Michael Morrissey | EXEL | Common Stock | Gift | -8.35% | -124,047 | 1,362,008 | 18 May 2026 | Direct | ||
| Christopher J. Senner | EXEL | Common Stock | Sale | -3.54% | $1,745,050 | $50.00 | -34,901 | 952,317 | 18 May 2026 | Direct |
| Brenda Hefti | EXEL | Common Stock | Sale | -5.84% | $332,641 | $50.21 | -6,625 | 106,762 | 18 May 2026 | Direct |
| Michael Morrissey | EXEL | Common Stock | Tax liability | -7.96% | -128,497 | 1,486,055 | 15 May 2026 | Direct | ||
| Christopher J. Senner | EXEL | Common Stock | Tax liability | -3.98% | -40,892 | 987,218 | 15 May 2026 | Direct | ||
| Patrick J. Haley | EXEL | Common Stock | Tax liability | -7.86% | -33,265 | 389,748 | 15 May 2026 | Direct | ||
| Brenda Hefti | EXEL | Common Stock | Tax liability | -5.35% | -6,411 | 113,387 | 15 May 2026 | Direct | ||
| Dana Aftab | EXEL | Common Stock | Tax liability | -4.57% | -30,578 | 638,192 | 15 May 2026 | Direct | ||
| Mary C. Beckerle | EXEL | Common Stock | Sale | -30.6% | $373,646 | $48.45 | -7,712 | 17,524 | 07 May 2026 | Direct |
| Mary C. Beckerle | EXEL | Common Stock | Options Exercise | 18% | 3,856 | 25,236 | 07 May 2026 | Direct | ||
| Mary C. Beckerle | EXEL | Option (right to buy) | Options Exercise | -23.1% | -3,856 | 12,854 | 07 May 2026 | Direct | ||
| Maria C. Freire | EXEL | Common Stock | Sale | -17% | $949,164 | $46.00 | -20,634 | 100,819 | 07 May 2026 | Direct |
| Maria C. Freire | EXEL | Common Stock | Options Exercise | 20.5% | 20,634 | 121,453 | 07 May 2026 | Direct | ||
| Maria C. Freire | EXEL | Option (right to buy) | Options Exercise | -100% | -20,634 | 0 | 07 May 2026 | Direct | ||
| George Poste | EXEL | Common Stock | Sale | -33.6% | $2,742,600 | $45.71 | -60,000 | 118,832 | 07 May 2026 | Direct |
| Michael Morrissey | EXEL | Common Stock | Gift | -5.51% | -109,676 | 1,880,280 | 06 May 2026 | By Trust | ||
| Dana Aftab | EXEL | Common Stock | Award | 8.44% | 52,018 | 668,124 | 26 Feb 2026 | Direct | ||
| Christopher J. Senner | EXEL | Common Stock | Award | 5.33% | 52,018 | 1,028,110 | 26 Feb 2026 | Direct | ||
| Brenda Hefti | EXEL | Common Stock | Award | 24% | 23,119 | 119,631 | 26 Feb 2026 | Direct | ||
| Patrick J. Haley | EXEL | Common Stock | Award | 10.6% | 40,459 | 422,367 | 26 Feb 2026 | Direct | ||
| Michael Morrissey | EXEL | Common Stock | Award | 11% | 160,437 | 1,614,552 | 26 Feb 2026 | Direct | ||
| Michael Morrissey | EXEL | Common Stock | Gift | -4.8% | -100,278 | 1,989,956 | 24 Feb 2026 | By Trust | ||
| Dana Aftab | EXEL | Common Stock | Sale | -7.22% | $2,132,351 | $44.50 | -47,918 | 616,106 | 24 Feb 2026 | Direct |
| Dana Aftab | EXEL | Common Stock | Sale | -4.31% | $1,324,868 | $44.35 | -29,873 | 664,024 | 19 Feb 2026 | Direct |
| Jack L. Wyszomierski | EXEL | Common Stock | Sale | -26.2% | $4,382,252 | $44.01 | -99,574 | 279,942 | 18 Feb 2026 | Direct |
| Jack L. Wyszomierski | EXEL | Common Stock | Options Exercise | 5.75% | 20,634 | 379,516 | 18 Feb 2026 | Direct | ||
| Jack L. Wyszomierski | EXEL | Option (right to buy) | Options Exercise | -100% | -20,634 | 0 | 18 Feb 2026 | Direct | ||
| Julie Smith | EXEL | Common Stock | Sale | -75.7% | $2,849,200 | $44.44 | -64,117 | 20,590 | 18 Feb 2026 | Direct |
| Julie Smith | EXEL | Common Stock | Options Exercise | 11449.5% | 64,117 | 64,677 | 18 Feb 2026 | Direct | ||
| Julie Smith | EXEL | Option (right to buy) | Options Exercise | -100% | -64,117 | 0 | 18 Feb 2026 | Direct | ||
| Michael Morrissey | EXEL | Common Stock | Gift | 6.37% | 125,094 | 2,090,234 | 18 Feb 2026 | By Trust | ||
| Michael Morrissey | EXEL | Common Stock | Gift | -7.92% | -125,094 | 1,454,115 | 18 Feb 2026 | Direct | ||
| Brenda Hefti | EXEL | Common Stock | Sale | -16.2% | $821,623 | $44.01 | -18,669 | 96,512 | 18 Feb 2026 | Direct |
| Julie Smith | EXEL | Common Stock | Sale | -67.3% | $1,838,145 | $43.33 | -42,422 | 20,590 | 17 Feb 2026 | Direct |
| Julie Smith | EXEL | Common Stock | Options Exercise | 206% | 42,422 | 63,012 | 17 Feb 2026 | Direct | ||
| Julie Smith | EXEL | Option (right to buy) | Options Exercise | -100% | -42,422 | 0 | 17 Feb 2026 | Direct | ||
| Christopher J. Senner | EXEL | Common Stock | Sale | -3.04% | $1,337,044 | $43.67 | -30,617 | 976,092 | 17 Feb 2026 | Direct |
| Patrick J. Haley | EXEL | Common Stock | Sale | -15.1% | $2,950,941 | $43.52 | -67,814 | 381,908 | 17 Feb 2026 | Direct |
| Michael Morrissey | EXEL | Common Stock | Gift | 14.6% | 250,736 | 1,965,140 | 17 Feb 2026 | By Trust | ||
| Michael Morrissey | EXEL | Common Stock | Gift | -13.7% | -250,736 | 1,579,209 | 17 Feb 2026 | Direct | ||
| Christopher J. Senner | EXEL | Common Stock | Tax liability | -3.44% | -35,870 | 1,006,709 | 15 Feb 2026 | Direct | ||
| Patrick J. Haley | EXEL | Common Stock | Tax liability | -6.54% | -31,483 | 449,722 | 15 Feb 2026 | Direct | ||
| Michael Morrissey | EXEL | Common Stock | Tax liability | -6.17% | -120,390 | 1,829,945 | 15 Feb 2026 | Direct | ||
| Dana Aftab | EXEL | Common Stock | Tax liability | -5.35% | -39,205 | 693,897 | 15 Feb 2026 | Direct | ||
| Brenda Hefti | EXEL | Common Stock | Tax liability | -4.5% | -5,430 | 115,181 | 15 Feb 2026 | Direct | ||
| Christopher J. Senner | EXEL | Common Stock | Sale | -3.18% | $1,473,954 | $43.00 | -34,278 | 1,042,579 | 13 Feb 2026 | Direct |
| Michael Morrissey | EXEL | Common Stock | Tax liability | -15.9% | -369,606 | 1,950,335 | 13 Feb 2026 | Direct | ||
| Michael Morrissey | EXEL | Common Stock | Options Exercise | 27.1% | 494,700 | 2,319,941 | 13 Feb 2026 | Direct |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.